The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A

Targeting a trough close to the assay sensitivity creates a unique problem in forecasting the dose needed for optimal treatment of hemophilia that, while still without solution, deserves consideration when making dosing decisions.